A dominant gain-of-function mutation in universal tyrosine kinase <i>SRC</i> causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies

Ernest Turro(University of Cambridge), Willem H. Ouwehand(NHS Blood and Transplant), Rémi Favier(Inserm), Deborah Whitehorn(University of Cambridge), Tadbir K. Bariana(Royal Free London NHS Foundation Trust), Wendy N. Erber(The University of Western Australia), Anouck Wijgaerts(KU Leuven), Andrew Mumford(University of Bristol), Myrto Kostadima(National Health Service), Mary Mathias(Ninewells Hospital), Keith Gomez(Royal Free London NHS Foundation Trust), Michele P. Lambert(Children's Hospital of Philadelphia), Dominik Selleslag(National Institutes of Health), Antony Attwood(Wellcome Sanger Institute), Michael Laffan(Hammersmith Hospital), Paquita Nurden(Plateforme Technologique d'Innovation Biomédicale), Sol Schulman(Beth Israel Deaconess Medical Center), Kathleen Stirrups(Queen Mary University of London), Augusto Rendon(University of Cambridge), Claire Lentaigne(Hammersmith Hospital), Chris Van Geet(KU Leuven), Sarah K. Westbury(University of Bristol), Sofia Papadia(University of Edinburgh), Kathelijne Peerlinck(KU Leuven), Jonathan Stephens(NHS Blood and Transplant), Kathleen Freson(KU Leuven), Christine Wittevrongel(KU Leuven), Anne M. Kelly(National Health Service), John R. Bradley(University of Cambridge), Sofie Ashford(University of Cambridge), Christopher J. Penkett(University of Cambridge), Daniel Greene(University of Cambridge), F. Lucy Raymond(Newcastle University), Carolyn M. Millar(National Health Service), Sylvia Richardson(Hammersmith Hospital), Steve Austin(National Health Service), Sri V. V. Deevi(University of Cambridge), Tamam Bakchoul(Universitätsmedizin Greifswald), Marc De Maeyer(KU Leuven), Peter Collins(Cardiff University), Ilenia Simeoni(University of Cambridge), David J. Perry(National Health Service), Chantal Thys(KU Leuven)
Science Translational Medicine
March 2, 2016
Cited by 144


Related Papers